Shareholders of FTAI Aviation Ltd. Should Contact Levi & Korsinsky Before March 18, 2025 to Discuss Your Rights – FTAI — Neutral
FTAI Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129709&wire=1 or contact Joseph E.

Investors who lost money on ICON Public Limited Company (ICLR) should contact Levi & Korsinsky about pending Class Action - ICLR — Neutral
ICLR Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=129710&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Neumora Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NMRA — Neutral
NMRA Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129711&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Notifies Shareholders of Regeneron Pharmaceuticals, Inc. (REGN) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
REGN Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=129707&wire=1 or contact Joseph E. Levi, Esq.

Shareholders that lost money on MGP Ingredients, Inc. (MGPI) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More — Neutral
MGPI Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=129708&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Walgreens Boots Alliance, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 – WBA — Neutral
WBA Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=129702&wire=1 or contact Joseph E. Levi, Esq.

Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc (GSK) — Neutral
GSK Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=129703&wire=1 or contact Joseph E. Levi, Esq.

SOUTHFIELD, Mich. , Feb. 14, 2025 /PRNewswire/ -- Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, today announced that its Board of Directors has declared a quarterly cash dividend of $0.77 per share on the Company's common stock.

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update — Neutral
CTOR CTXR PRNewsWire — February 14, 2025CRANFORD, N.J. , Feb. 14, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal first quarter ended December 31, 2024.

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update — Neutral
CTOR PRNewsWire — February 14, 2025CRANFORD, N.J. , Feb. 14, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal first quarter ended December 31, 2024.

MDU Resources Announces Plans to Invest in Badger Wind Farm — Neutral
MDU PRNewsWire — February 14, 2025BISMARCK, N.D. , Feb. 14, 2025 /PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) is pleased to announce that its subsidiary, Montana-Dakota Utilities Co. (MDU), has signed a purchase agreement to acquire a 49% ownership interest in the Badger Wind Farm.

Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results — Neutral
LSH PRNewsWire — February 14, 2025ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.

Class Action Filed Against ModivCare Inc. (MODV) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
MODV Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your ModivCare Inc. (NASDAQ:MODV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/modivcare-inc-lawsuit-submission-form?prid=129712&wire=1 or contact Joseph E. Levi, Esq.

KKR Real Estate Finance Trust Inc. to Present at Citi's 30th Annual Global Property CEO Conference — Neutral
KREF Business Wire — February 14, 2025NEW YORK--(BUSINESS WIRE)--KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) announced today that Matt Salem, Chief Executive Officer, will present at Citi's 30th Annual Global Property CEO Conference on Monday, March 3, 2025, at 11:40AM ET. A live audio webcast of the presentation will be available on the Investor Center section of KREF's website at http://www.kkrreit.com/investor-relations/events-and-presentations. For those unable to listen to the live audio webcast, a replay will be.

Fiverr to Unveil a Transformative New Era of Work in Live Broadcast from New York City on February 18, 2025 — Neutral
FVRR GlobeNewsWire — February 14, 2025NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The world of talent is evolving and Fiverr (NYSE: FVRR), the global company changing the way the world works together, will be broadcasting live to the public from New York City to unveil a transformative new era of work. The livestream will feature an exclusive keynote from Fiverr's founder and CEO, Micha Kaufman, followed by an insightful conversation on what's ahead.

Steel Partners Holdings Declares Regular Quarterly Distribution On its Series A Preferred Units — Neutral
SPLP Business Wire — February 14, 2025NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (NYSE: SPLP), a diversified global holding company, today announced that its board of directors has declared a regular quarterly cash distribution of $.375 per unit, payable March 15, 2025, to unitholders of record as of March 1, 2025, on its 6% Series A Preferred Units, no par value ("Series A Preferred"). Any future determination to declare distributions on its units of Series A Preferred, and any determination to pay such distributions.

American Battery Technology Company Releases Second Quarter Fiscal Year 2025 Financial Report — Neutral
ABAT GlobeNewsWire — February 14, 2025Company demonstrates significantly increased throughput at its first lithium-ion battery recycling facility, and continues development of two additional critical mineral facilities Company demonstrates significantly increased throughput at its first lithium-ion battery recycling facility, and continues development of two additional critical mineral facilities

Shareholders of ConnectOne Bancorp, Inc. and The First of Long Island Corporation Approve Proposed Merger — Neutral
CNOB GlobeNewsWire — February 14, 2025ENGLEWOOD CLIFFS, N.J. and MELVILLE, N.Y., Feb. 14, 2025 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), and The First of Long Island Corporation (Nasdaq: FLIC) (“First of Long Island”), parent company of The First National Bank of Long Island, today announced that at separate special meetings the shareholders of both companies approved proposals relating to the pending merger of ConnectOne and First of Long Island. Closing of the transaction is expected to occur in the second quarter of 2025, subject to the receipt of regulatory approval and other …

APLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT — Neutral
APLT GlobeNewsWire — February 14, 2025NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline.

ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA — Neutral
NMRA Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Neumora Therapeutics, Inc.(NASDAQ:NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Offering Documents") issued in connection with Neumora's September 2023 initial public offering (the "IPO"), of the important April 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Neumora common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
